SCHEMBL13870934

SCHEMBL13870934

COc1cc2ccc(-c3cc(C)ccc3C)nc2cc1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 3/20 0.43
PDGFRA P16234 3/20 0.43
ACHE P22303 1/20 0.43
ALDH1A1 P00352 5/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
KDM4E B2RXH2 3/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
NQO2 P16083 1/20 0.40
PDE10A Q9Y233 2/20 0.39
MCHR1 Q99705 1/20 0.39
NFKBIA P25963 1/20 0.38
RELA Q04206 1/20 0.38
GAA P10253 2/20 0.38
MAPT P10636 2/20 0.38
GLA P06280 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13870937 0.88 PDGFRB (0.47) PDGFRBPDGFRAACHEALDH1A1SMN1; SMN2
SCHEMBL16487807 0.86 KMT2A (0.40) ALDH1A1KDM4EPDE10AMCHR1NFKBIA
SCHEMBL13870938 0.84 NQO2 (0.46) PDGFRBPDGFRAALDH1A1SMN1; SMN2KDM4E
SCHEMBL13870905 0.83 CYP1A2 (0.41) ALDH1A1SMN1; SMN2KDM4ERAB9AGAA
SCHEMBL8887931 0.83 MEN1 (0.50) PDGFRBPDGFRAALDH1A1SMN1; SMN2KDM4E
SCHEMBL16488129 0.81 PSMB5 (0.43) PDGFRBPDGFRAALDH1A1KDM4EMAPT
SCHEMBL13870925 0.79 KDM4E (0.49) PDGFRBPDGFRAALDH1A1SMN1; SMN2KDM4E
SCHEMBL13870936 0.77 PDGFRB (0.45) PDGFRBPDGFRAALDH1A1SMN1; SMN2KDM4E
SCHEMBL13870942 0.76 ALDH1A1 (0.36) ALDH1A1SMN1; SMN2KDM4EMCHR1MAPT
SCHEMBL13870939 0.76 KDM4E (0.55) PDGFRBPDGFRAALDH1A1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IK, G6PD, EYA2 PDGFRB 1748/4885PDGFRA 1137/4885ACHE 855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.